Article 1 to 1 out of 1 concerning Ruhr-Universität Bochum (RUB)
Stable dust for preventing hay fever and allergic asthma(01 Jul 2008) Ascenion receives equity in Protectimmun March 2007 saw the founding of a new company, Protectimmun GmbH, to exploit groundbreaking research in allergy prevention from the Research Center Borstel (FZB) and the Ruhr-Universität Bochum. The goal of the company is to develop a drug that will ...
Top
